Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 9 | 2023 | 235 | 1.000 |
Why?
|
| Alzheimer Disease | 8 | 2023 | 409 | 1.000 |
Why?
|
| Dementia | 4 | 2021 | 127 | 0.970 |
Why?
|
| Aging | 10 | 2023 | 352 | 0.940 |
Why?
|
| Models, Statistical | 2 | 2016 | 36 | 0.850 |
Why?
|
| Longitudinal Studies | 9 | 2019 | 363 | 0.670 |
Why?
|
| Music | 1 | 2021 | 8 | 0.660 |
Why?
|
| Death | 1 | 2021 | 11 | 0.660 |
Why?
|
| Literacy | 1 | 2021 | 9 | 0.660 |
Why?
|
| Aged | 25 | 2023 | 1860 | 0.660 |
Why?
|
| Educational Status | 1 | 2021 | 60 | 0.650 |
Why?
|
| Cognition | 8 | 2023 | 337 | 0.620 |
Why?
|
| Humans | 34 | 2023 | 5837 | 0.610 |
Why?
|
| Brain | 6 | 2023 | 331 | 0.540 |
Why?
|
| Female | 28 | 2023 | 3346 | 0.520 |
Why?
|
| Male | 27 | 2023 | 3399 | 0.500 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 25 | 0.500 |
Why?
|
| Cognition Disorders | 6 | 2020 | 237 | 0.490 |
Why?
|
| Biostatistics | 1 | 2016 | 3 | 0.480 |
Why?
|
| Aged, 80 and over | 17 | 2023 | 1034 | 0.450 |
Why?
|
| Odds Ratio | 1 | 2012 | 60 | 0.380 |
Why?
|
| Family | 2 | 2021 | 26 | 0.320 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 94 | 0.320 |
Why?
|
| Risk Factors | 8 | 2021 | 499 | 0.300 |
Why?
|
| Hippocampus | 3 | 2019 | 61 | 0.260 |
Why?
|
| Hospitalization | 2 | 2019 | 86 | 0.260 |
Why?
|
| Depression | 2 | 2020 | 113 | 0.250 |
Why?
|
| Cognitive Aging | 2 | 2018 | 27 | 0.250 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 39 | 0.250 |
Why?
|
| Perception | 3 | 2021 | 30 | 0.220 |
Why?
|
| Intracranial Aneurysm | 2 | 2018 | 10 | 0.220 |
Why?
|
| Computer Simulation | 2 | 2016 | 54 | 0.210 |
Why?
|
| Stress, Psychological | 2 | 2021 | 58 | 0.210 |
Why?
|
| Brazil | 2 | 2021 | 10 | 0.210 |
Why?
|
| Interviews as Topic | 2 | 2021 | 44 | 0.210 |
Why?
|
| Independent Living | 2 | 2021 | 62 | 0.210 |
Why?
|
| Neuropsychological Tests | 7 | 2019 | 309 | 0.200 |
Why?
|
| Arteriolosclerosis | 1 | 2023 | 14 | 0.200 |
Why?
|
| Middle Aged | 11 | 2021 | 1775 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2023 | 10 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 24 | 0.190 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2023 | 28 | 0.190 |
Why?
|
| Retrospective Studies | 4 | 2021 | 584 | 0.190 |
Why?
|
| Lewy Bodies | 3 | 2019 | 56 | 0.190 |
Why?
|
| Memory, Episodic | 2 | 2019 | 26 | 0.180 |
Why?
|
| Ventriculostomy | 2 | 2012 | 3 | 0.170 |
Why?
|
| Disease Outbreaks | 2 | 2013 | 15 | 0.170 |
Why?
|
| Swine Diseases | 2 | 2012 | 2 | 0.170 |
Why?
|
| Mathematics | 1 | 2021 | 25 | 0.170 |
Why?
|
| Writing | 1 | 2021 | 9 | 0.170 |
Why?
|
| Reading | 1 | 2021 | 9 | 0.170 |
Why?
|
| Social Discrimination | 1 | 2021 | 5 | 0.170 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2012 | 2 | 0.160 |
Why?
|
| Influenza, Human | 2 | 2013 | 9 | 0.160 |
Why?
|
| Adenoviruses, Human | 2 | 2009 | 2 | 0.150 |
Why?
|
| Neurofibrillary Tangles | 2 | 2017 | 33 | 0.150 |
Why?
|
| Memory Disorders | 1 | 2020 | 48 | 0.150 |
Why?
|
| Disease Progression | 2 | 2019 | 157 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 2 | 2017 | 41 | 0.150 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 4 | 0.150 |
Why?
|
| Logistic Models | 2 | 2016 | 109 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2019 | 48 | 0.140 |
Why?
|
| Emergencies | 1 | 2019 | 18 | 0.140 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 37 | 0.140 |
Why?
|
| Learning | 1 | 2018 | 23 | 0.130 |
Why?
|
| Antibodies, Bacterial | 2 | 2008 | 2 | 0.130 |
Why?
|
| Ambulatory Care | 1 | 2017 | 16 | 0.130 |
Why?
|
| Animals | 5 | 2013 | 1349 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2017 | 71 | 0.130 |
Why?
|
| Neuropathology | 1 | 2017 | 17 | 0.130 |
Why?
|
| Likelihood Functions | 1 | 2016 | 9 | 0.120 |
Why?
|
| Linear Models | 1 | 2016 | 64 | 0.120 |
Why?
|
| Brain Chemistry | 1 | 2016 | 11 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 28 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 15 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2016 | 111 | 0.110 |
Why?
|
| Autopsy | 3 | 2023 | 67 | 0.110 |
Why?
|
| Swine | 2 | 2012 | 24 | 0.110 |
Why?
|
| Occupational Exposure | 3 | 2013 | 4 | 0.110 |
Why?
|
| Adult | 7 | 2018 | 1670 | 0.110 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 5 | 0.100 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 4 | 0.100 |
Why?
|
| Pyridines | 1 | 2014 | 13 | 0.100 |
Why?
|
| Infant | 4 | 2023 | 184 | 0.100 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2013 | 1 | 0.100 |
Why?
|
| Rural Population | 1 | 2013 | 3 | 0.100 |
Why?
|
| Antibodies, Viral | 1 | 2013 | 9 | 0.100 |
Why?
|
| Influenza A virus | 1 | 2012 | 6 | 0.100 |
Why?
|
| Sclerosis | 3 | 2019 | 26 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 207 | 0.090 |
Why?
|
| United States | 5 | 2019 | 502 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2019 | 406 | 0.090 |
Why?
|
| Third Ventricle | 1 | 2012 | 1 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 19 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 2 | 0.080 |
Why?
|
| Stents | 1 | 2010 | 11 | 0.080 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2021 | 16 | 0.080 |
Why?
|
| Adenovirus Infections, Human | 1 | 2009 | 1 | 0.080 |
Why?
|
| Adenoviridae Infections | 1 | 2009 | 1 | 0.080 |
Why?
|
| Young Adult | 4 | 2013 | 421 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2012 | 174 | 0.070 |
Why?
|
| Animal Husbandry | 1 | 2008 | 1 | 0.070 |
Why?
|
| Streptococcus suis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 3 | 0.070 |
Why?
|
| Child | 4 | 2012 | 339 | 0.070 |
Why?
|
| Veterinarians | 1 | 2007 | 1 | 0.070 |
Why?
|
| Influenza A Virus, H5N2 Subtype | 1 | 2007 | 1 | 0.070 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2007 | 1 | 0.060 |
Why?
|
| Influenza in Birds | 1 | 2007 | 1 | 0.060 |
Why?
|
| Paramyxoviridae Infections | 1 | 2006 | 1 | 0.060 |
Why?
|
| Metapneumovirus | 1 | 2006 | 1 | 0.060 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 5 | 0.060 |
Why?
|
| Deer | 1 | 2006 | 1 | 0.060 |
Why?
|
| Ehrlichiosis | 1 | 2006 | 1 | 0.060 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2006 | 1 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 203 | 0.060 |
Why?
|
| Chicago | 2 | 2017 | 239 | 0.060 |
Why?
|
| Aneurysm, Ruptured | 2 | 2018 | 8 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2019 | 411 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 53 | 0.050 |
Why?
|
| Age Factors | 2 | 2016 | 181 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 26 | 0.050 |
Why?
|
| Adolescent | 3 | 2012 | 488 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2014 | 601 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 22 | 0.040 |
Why?
|
| Self Report | 1 | 2020 | 53 | 0.040 |
Why?
|
| Medicare | 1 | 2019 | 30 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 136 | 0.030 |
Why?
|
| Zoonoses | 2 | 2008 | 3 | 0.030 |
Why?
|
| Iowa | 2 | 2008 | 3 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2017 | 22 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 18 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 16 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 46 | 0.030 |
Why?
|
| Brain Stem | 1 | 2016 | 6 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 28 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2015 | 11 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 36 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 64 | 0.030 |
Why?
|
| Reaction Time | 1 | 2015 | 39 | 0.030 |
Why?
|
| Memory | 1 | 2015 | 61 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 333 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2014 | 32 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 13 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 19 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 19 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2014 | 37 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 78 | 0.030 |
Why?
|
| Cambodia | 1 | 2013 | 4 | 0.020 |
Why?
|
| Optic Chiasm | 1 | 2012 | 1 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2012 | 2 | 0.020 |
Why?
|
| Central Nervous System Infections | 1 | 2012 | 2 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2012 | 7 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 37 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 35 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 57 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 24 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 100 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 284 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 82 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2010 | 2 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 7 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 60 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2010 | 12 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2010 | 15 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 129 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2009 | 7 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 150 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2009 | 2 | 0.020 |
Why?
|
| Connecticut | 1 | 2009 | 3 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 3 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 3 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2009 | 10 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2009 | 153 | 0.020 |
Why?
|
| Serotyping | 1 | 2008 | 5 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2007 | 1 | 0.020 |
Why?
|
| Peru | 1 | 2007 | 1 | 0.020 |
Why?
|
| Poultry | 1 | 2007 | 1 | 0.020 |
Why?
|
| Chickens | 1 | 2007 | 10 | 0.020 |
Why?
|
| Phylogeny | 1 | 2006 | 14 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2006 | 12 | 0.020 |
Why?
|
| Hospitals | 1 | 2006 | 31 | 0.020 |
Why?
|
| Arachnid Vectors | 1 | 2006 | 1 | 0.010 |
Why?
|
| Ixodes | 1 | 2006 | 1 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2006 | 2 | 0.010 |
Why?
|
| Animals, Wild | 1 | 2006 | 2 | 0.010 |
Why?
|
| Sentinel Surveillance | 1 | 2006 | 3 | 0.010 |
Why?
|
| Disease Reservoirs | 1 | 2006 | 4 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 35 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 132 | 0.010 |
Why?
|